Sophia Hober

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Ge Healthcare Bio-Sciences Ab, Affibody Ab, Cytiva Bioprocess R&d Ab. Active years: 2004-2023.

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 58.3

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 1.5

ph-index = 9

Forward Citations = 205(Granted Patents)

Company Filing History:

5 out of 371

Ge Healthcare Bio-Sciences Ab

Cytiva Bioprocess R&d Ab

patents

4. 1 out of 1

Ge Health Bio-Sciences Ab

patent

5. 1 out of 135

Ge Healthcare Bio-Sciences Corp.

patents

6. 1 out of 44

Ge Healthcare Bioprocess R&d Ab

patents

Years Active: 2004-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11820802 - Ligand and use thereof (2023-11-21),

2. 11505576 - Polypeptides based on a scaffold (2022-11-22),

3. 10918971 - Mutated immunoglobulin-binding protein (2021-02-16),

4. 9534023 - Mutated immunoglobulin-binding protein (2017-01-03),

5. 9296791 - Mutant protein (2016-03-29),

6. 9156892 - Mutated immunoglobulin-binding protein (2015-10-13),

7. 8916689 - Method for labeling of compounds (2014-12-23),

8. 8354510 - Mutant protein (2013-01-15),

9. 8198404 - Mutated immunoglobulin-binding protein (2012-06-12),

10. 7834158 - Mutated immunoglobulin-binding protein (2010-11-16),

11. 7709209 - Protein ligands (2010-05-04),

12. 6831161 - Method of affinity separation and ligands for use therein (2004-12-14),

Title: Sophia Hober - Innovative Inventor from Stockholm

Introduction: Sophia Hober is a pioneering inventor based in Stockholm, Sweden, known for her groundbreaking contributions to the field of biotechnology.

Latest Patents: Sophia Hober holds several patents in the area of protein engineering and biotechnology, with her most recent patent focusing on a novel method for protein purification.

Career Highlights: With a career spanning over two decades, Sophia Hober has made significant advancements in the development of protein-based therapeutics, earning her recognition as a leading expert in the field.

Collaborations: Throughout her career, Sophia Hober has collaborated with top research institutions and biopharmaceutical companies to further the application of her innovative technologies in the healthcare industry.

Conclusion: Sophia Hober's dedication to innovation and her relentless pursuit of scientific excellence continue to inspire the next generation of inventors and researchers in the field of biotechnology.

Profile summary based on public USPTO records.